Charles Schwab’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-511,623
| Closed | -$9.95M | – | 3213 |
|
|
2018
Q1 | $9.95M | Sell |
511,623
-65,755
| -11% | -$1.28M | 0.01% | 1501 |
|
|
2017
Q4 | $9.61M | Sell |
577,378
-2,171
| -0.4% | -$36.2K | 0.01% | 1498 |
|
|
2017
Q3 | $11.8M | Buy |
579,549
+31,807
| +6% | +$646K | 0.01% | 1300 |
|
|
2017
Q2 | $8.82M | Buy |
547,742
+558
| +0.1% | +$8.98K | 0.01% | 1446 |
|
|
2017
Q1 | $6.92M | Buy |
547,184
+39,801
| +8% | +$503K | 0.01% | 1568 |
|
|
2016
Q4 | $6.72M | Buy |
507,383
+100,564
| +25% | +$1.33M | 0.01% | 1544 |
|
|
2016
Q3 | $9.64M | Sell |
406,819
-4,944
| -1% | -$117K | 0.01% | 1194 |
|
|
2016
Q2 | $11.9M | Buy |
411,763
+76,500
| +23% | +$2.2M | 0.01% | 955 |
|
|
2016
Q1 | $10.7M | Buy |
335,263
+67,743
| +25% | +$2.17M | 0.01% | 1000 |
|
|
2015
Q4 | $11.4M | Buy |
267,520
+8,390
| +3% | +$359K | 0.02% | 925 |
|
|
2015
Q3 | $9.12M | Sell |
259,130
-28,095
| -10% | -$989K | 0.01% | 1055 |
|
|
2015
Q2 | $13.2M | Buy |
287,225
+12,934
| +5% | +$594K | 0.02% | 821 |
|
|
2015
Q1 | $12.9M | Buy |
274,291
+46,205
| +20% | +$2.17M | 0.02% | 824 |
|
|
2014
Q4 | $7.23M | Sell |
228,086
-18,987
| -8% | -$602K | 0.01% | 1151 |
|
|
2014
Q3 | $5.86M | Sell |
247,073
-12,459
| -5% | -$295K | 0.01% | 1237 |
|
|
2014
Q2 | $7.78M | Sell |
259,532
-490,589
| -65% | -$14.7M | 0.01% | 1033 |
|
|
2014
Q1 | $19.8M | Buy |
750,121
+5,243
| +0.7% | +$139K | 0.04% | 464 |
|
|
2013
Q4 | $18.7M | Buy |
744,878
+31,508
| +4% | +$792K | 0.04% | 447 |
|
|
2013
Q3 | $15.2M | Buy |
713,370
+59,401
| +9% | +$1.26M | 0.03% | 481 |
|
|
2013
Q2 | $13.3M | Buy |
+653,969
| New | +$13.3M | 0.03% | 488 |
|